BBC News | Health | World Edition
No quick fix for diabetes risk
|
|
Exercise and diet are key to prevent diabetes in high-risk people, say researchers who found two drug treatments offer no benefit.
|
|
03/15/2010 12:01 AM
|
|
Gum disease 'link' to early birth
|
|
Successful treatment for gum disease cuts the risk of pregnant women giving birth early, say US researchers.
|
|
03/14/2010 12:29 AM
|
|
Obese drinkers face 'double hit'
|
|
Obese women drinking little more than a glass of wine a day have double the risk of liver disease, experts warn.
|
|
03/13/2010 12:09 AM
|
|
New blood pressure approach urged
|
|
Occasionally high blood pressure may be a greater indicator of stroke risk than consistently high readings, researchers say.
|
|
03/12/2010 12:02 AM
|
|
Women on pill 'may live longer'
|
|
Women who took the contraceptive pill are less likely to die of cancer and heart disease, a long-term study has found.
|
|
03/12/2010 07:38 AM
|
|
Home 'cervical cancer' test hope
|
|
At-home screening tests for the virus responsible for most cervical cancers could detect many more cases, say researchers.
|
|
03/12/2010 12:02 AM
|
|
New York agrees 9/11 dust payout
|
|
New York City agrees to pay up to 657m US Dollars (437m Sterling) to thousands of rescue and clean-up workers at the 9/11 attacks site.
|
|
03/12/2010 09:15 AM
|
|
GPs 'lax' on cholesterol targets
|
|
Many lives could be saved if GPs followed guidelines for reducing cholesterol in those at high risk of heart disease, a study suggests.
|
|
03/11/2010 01:08 AM
|
|
Vitiligo skin graft 'effective'
|
|
Skin transplant surgery can be an effective way of treating the skin disease vitiligo, say US researchers.
|
|
03/11/2010 01:13 AM
|
|
Hospital rap over medicine errors
|
|
Too many patients in England and Wales are not getting their medicines in hospital, a safety watchdog says.
|
|
03/11/2010 01:01 AM
|
|
'Too many' baby hip cases ignored
|
|
A national charity says parents and health professionals need to check babies' hips in order to prevent pain and permanent disability.
|
|
03/15/2010 09:41 AM
|
|
'No proof' acupuncture aids IVF
|
|
There is no evidence acupuncture or Chinese herbal medicine boost the chance of IVF success, fertility experts warn.
|
|
03/10/2010 12:17 AM
|
|
|
Health News from Medical News Today
AMA Welcomes Big Investment In Medical Training, Australia
|
|
AMA President, Dr Andrew Pesce, said today that the AMA welcomes the Government's significant investment in medical training with the announcement of big increases in the number of medical training places across the board. The Government has announced there will be 1200 general practice training places by 2014, 975 Pre-vocational General Practice Placements Program (PGPPP) places by 2013, and 900 specialist training positions in private, community and rural settings by 2014...


|
|
03/15/2010 08:00 PM
|
|
Functional Technologies Develops Yeast Solution For Acrylamide In Processed Foods
|
|
Functional Technologies Corp. (TSX VENTURE:FEB), a world leader in yeast research and development, announced today that it has developed, tested and filed patent applications for yeast technology that reduces the formation of acrylamide, a carcinogen formed when starchy foods are baked, fried or toasted. Recognized globally as a serious food safety issue since 2002, acrylamide has been found in many widely consumed foods, including bread, cookies, crackers, baby food, breakfast cereal, French fries and potato chips...


|
|
03/15/2010 12:00 PM
|
|
Arcadia Biosciences Completes First Commercial Production Of SONOVA™ 400 High GLA Safflower Oil
|
|
Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, announced today that it has successfully completed the first commercial production of SONOVA™ 400 High GLA Safflower Oil. Seed produced by the first High GLA Safflower crop, grown during 2009, was processed to produce commercial quantities of SONOVA™ 400 oil, which is now available for distribution as a key ingredient in dietary supplements...


|
|
03/15/2010 12:00 PM
|
|
Kevin P. Black, MD, Elected To American Academy Of Orthopaedic Surgeons Board Of Directors
|
|
Orthopaedic surgeon Kevin P. Black, MD, of Hershey, Penn., was elected to the Board of Directors of the American Academy of Orthopaedic Surgeons (AAOS) at the organization's 2010 Annual Meeting in New Orleans. "It's an enormous honor to be elected to the AAOS Board of Directors," said Dr. Black. "I'm looking forward to working with and learning from the other members of the Board and having the opportunity to contribute to our great profession and ultimately the patients for whom we care." Dr...


|
|
03/15/2010 11:00 AM
|
|
AngioScore Announces Favorable Results From The MASCOT Trial
|
|
AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, announced today favorable clinical trial results from the MASCOT Trial, an important study evaluating the AngioSculpt® PTA Scoring Balloon Catheter for the treatment of femoro-popliteal PAD (peripheral artery disease). "PAD is one of the fastest-growing segments of the Endovascular Market, with an estimated two million annual procedures worldwide...


|
|
03/15/2010 11:00 AM
|
|
FDA Allows IND For Bio-Path Holdings' Liposomal Grb-2
|
|
Bio-Path Holdings, Inc. (OTCBB: BPTH), a publicly traded biotechnology company with drug development operations in Houston, Texas, announced that the U.S. Food and Drug Administration (FDA) has allowed an IND (Investigational New Drug) for the Company's lead cancer drug candidate liposomal Grb-2 to proceed into clinical trials...


|
|
03/15/2010 11:00 AM
|
|
Patient Advocacy Group Asks FDA To Enhance Its Enforcement Of Unapproved Drugs Initiative
|
|
The National Minority Quality Forum (The Forum) is launching a new public information campaign aimed to help educate consumers, physicians, and policymakers about the risks associated with prescribing and taking unapproved drugs that have not been subjected to the rigorous Food and Drug Administration's (FDA) review and approval process. Unapproved drugs can be dangerous - or even deadly - to patients as a result of the lack of testing, unknown or unregulated ingredients, improper labeling, and as a result of this lack of information, the inability to predict drug to drug interactions...


|
|
03/15/2010 11:00 AM
|
|
Risk Stratification Imperative To Treatment Selection In Patients With AML
|
|
Using risk stratification to assist in treatment selection was just one of the focal points at a recent presentation of the NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines™) for Acute Myeloid Leukemia (AML) at the NCCN 15th Annual Conference. B. Douglas Smith, MD of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and a member of the NCCN Guidelines Panel for AML, spoke about the challenges in treating AML as well as recent updates to the NCCN Guidelines™. Dr...


|
|
03/15/2010 11:00 AM
|
|
Ligand Announces Approval For Revolade(R) In Europe
|
|
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that GlaxoSmithKline (NYSE: GSK) was granted marketing authorization from the European Commission (EC) for Revolade® (eltrombopag) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP). Eltrombopag is indicated for adult chronic ITP splenectomized patients who have not responded (are refractory) to other treatments, such as corticosteroids and immunoglobulins...


|
|
03/15/2010 11:00 AM
|
|
Frost & Sullivan Lauds Positron Corporation For Cardiac-Focused PET Molecular Imaging Scanner Attrius™
|
|
Based on its recent analysis of the cardiac molecular imaging systems market, Frost & Sullivan recognizes Positron Corporation with the 2010 North American Award for New Product Innovation, for its pioneering cardiac positron emission tomography (PET) scanner, Attrius™. The Attrius™ was developed and optimized for molecular imaging of the heart, making it the ideal solution for cardiologists and hospitals looking to add high accuracy, cost effective imaging technology...


|
|
03/15/2010 11:00 AM
|
|
Cancer Care At The End Of Life: When Is Enough, Enough?
|
|
Despite the advances and groundbreaking research being performed in the area of cancer treatment, sometimes cancer cannot be cured. In this situation, patients and their families are faced with complex emotions and a variety of end of life issues and decisions. ABC News veteran and anchor Sam Donaldson shared his own perspective as a cancer survivor while moderating a roundtable of notable panelists at the NCCN 15th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ on March 11, 2010. "I had to figure out who I was going to be on my own." Mr...


|
|
03/15/2010 11:00 AM
|
|
Progenics To Advance Oral Methylnaltrexone Into Late Stage Clinical Development
|
|
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that it plans to advance oral methylnaltrexone for the treatment of opioid-induced constipation (OIC) into late stage clinical development and will commence a phase 2b/3 clinical trial of a methylnaltrexone tablet in chronic-pain patients in the second half of 2010. Progenics also announced data from a clinical trial of this methylnaltrexone tablet. The tablet form of oral methylnaltrexone was developed by Progenics' former collaboration partner Wyeth...


|
|
03/15/2010 11:00 AM
|
|
|
Y! Health News Search RSS Feed
Antiseptic baths help fight 'superbug' infections (Reuters)
|
|
Reuters - Bathing severely injured intensive-care patients with antiseptic-soaked washcloths can cut their risk of developing certain types of infections, and also seems to help keep drug-resistant bacteria at bay, new research shows.
|
|
03/15/2010 10:30 PM
|
|
Arteries improve after smokers quit, study finds (AP)
|
|
AP - Quitting smoking can turn back time.
|
|
03/15/2010 09:06 PM
|
|
Are Stock Market Woes Bad for the Heart? (HealthDay)
|
|
HealthDay - SATURDAY, March 13 (HealthDay News) -- When the stock market
declines, do heart attacks go up? That's what Duke University Medical
Center researchers are wondering based on an analysis of data collected
during the current U.S. economic crisis.
|
|
03/15/2010 09:03 PM
|
|
2 Drugs Fail to Prevent Diabetes in the Overweight (HealthDay)
|
|
HealthDay - SUNDAY, March 14 (HealthDay News) -- Hopes that two available drugs
could help prevent diabetes and the problems it causes in overweight
people with poor sugar metabolism have been dashed by a major
international study.
|
|
03/15/2010 09:03 PM
|
|
Marathoners Face Greater Risk of Artery Problems (HealthDay)
|
|
HealthDay - SATURDAY, March 13 (HealthDay News) -- If regular exercise such
as jogging is good for the heart, then turbo-charged workouts like
training for marathons must be even better, right?
|
|
03/15/2010 09:03 PM
|
|
Psoriasis Tied to Raised Heart Risk (HealthDay)
|
|
HealthDay - SATURDAY, March 13 (HealthDay News) -- The common skin ailment
psoriasis may boost the risk for heart attack, stroke and other
cardiovascular woes, probably through a shared inflammatory response, a
new Danish study found.
|
|
03/15/2010 09:03 PM
|
|
Many WTC Responders Show Signs of Heart Trouble (HealthDay)
|
|
HealthDay - SATURDAY, March 13 (HealthDay News) -- Police who responded on
9/11 to the collapsing World Trade Center towers appear to be at greater
risk for heart problems compared with people in the general population, a
new study finds.
|
|
03/15/2010 09:03 PM
|
|
Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2
Diabetics (HealthDay)
|
|
HealthDay - SUNDAY, March 14 (HealthDay News) -- Two sets of results from a large
U.S. government-sponsored trial find that neither aggressive treatment of
cholesterol nor of blood pressure lowers the risk of heart events in
people with type 2 diabetes.
|
|
03/15/2010 09:03 PM
|
|
More Evidence That Swings in Blood Pressure Raise Stroke
Risk (HealthDay)
|
|
HealthDay - SUNDAY, March 14 (HealthDay News) --Following on recent, similar
research, a large five-year study points to fluctuations in blood pressure
over time as a key indicator of stroke risk.
|
|
03/15/2010 09:03 PM
|
|
Combination Treatment May Help Depressed Alcoholics (HealthDay)
|
|
HealthDay - MONDAY, March 15 (HealthDay News) -- Combined treatment with the
antidepressant Zoloft (sertraline) and the alcoholism drug naltrexone
improves the likelihood that people with both major depression and alcohol
dependence will be able to stop drinking, U.S. researchers report.
|
|
03/15/2010 09:03 PM
|
|
|